Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Kenneth van Golen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Physiology
Living Beings
Anatomy
Phenomena
Sign-in to see full Profile
Network (preview)
17
Merajver, Sofia
7
Kleer, Celina
7
Wu, Zhi-Fen
4
van Golen, Cynthia
3
Pienta, Kenneth
3
Price, Janet
3
Pan, Quintin
3
Brewer, George
3
Bao, Li Wei
3
Cooper, Carlton
3
Feldman, Eva
2
Dick, Robert
2
Dirix, Luc
2
Keller, Evan
2
Hall, Christopher
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Kenneth van Golen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Hall Christopher L; Dubyk Cara W; Riesenberger Tracy A; Shein Daniel; Keller Evan T; van Golen Kenneth L
Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase.
Neoplasia (New York, N.Y.) 2008;10(8):797-803.
-
2008: van Golen Kenneth L; Ying Chi; Sequeira Linda; Dubyk Cara W; Reisenberger Tracy; Chinnaiyan Arul M; Pienta Kenneth J; Loberg Robert D
CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac.
Journal of cellular biochemistry 2008;104(5):1587-97.
-
2008: Cooper Carlton R; Graves Bianca; Pruitt Freddie; Chaib Hassan; Lynch Jill E; Cox Andrew Koemeter; Sequeria Linda; van Golen Kenneth L; Evans Angelo; Czymmek Kirk; Bullard Rebecca S; Donald Carlton D; Sol-Church Katia; Gendernalik James D; Weksler Babette; Farach-Carson Mary C; Macoska Jill A; Sikes Robert A; Pienta Kenneth J
Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha.
Journal of cellular biochemistry 2008;104(6):2298-309.
-
2008: Sequeira Linda; Dubyk Cara W; Riesenberger Tracy A; Cooper Carlton R; van Golen Kenneth L
Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis.
Clinical & experimental metastasis 2008;25(5):569-79.
-
2008: Miles Fayth L; Pruitt Freddie L; van Golen Kenneth L; Cooper Carlton R
Stepping out of the flow: capillary extravasation in cancer metastasis.
Clinical & experimental metastasis 2008;25(4):305-24.
-
2006: van Golen Kenneth L
Is caveolin-1 a viable therapeutic target to reduce cancer metastasis?
Expert opinion on therapeutic targets 2006;10(5):709-21.
-
2006: Hall Christopher L; Dai JinLu; van Golen Kenneth L; Keller Evan T; Long Michael W
Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
Cancer research 2006;66(17):8648-54.
-
2006: van Golen Cynthia M; Schwab Tracy S; Kim Bhumsoo; Soules Mary E; Su Oh Sang; Fung Kevin; van Golen Kenneth L; Feldman Eva L
Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.
Cancer research 2006;66(13):6570-8.
-
2006: Yao H; Dashner E J; van Golen C M; van Golen K L
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility.
Oncogene 2006;25(16):2285-96.
-
2006: Van Laere Steven J; Van den Eynden Gert G; Van der Auwera Ilse; Vandenberghe Melanie; van Dam Peter; Van Marck Eric A; van Golen Kenneth L; Vermeulen Peter B; Dirix Luc Y
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Breast cancer research and treatment 2006;95(3):243-55.
-
2006: Van den Eynden Gert G; Van Laere Steven J; Van der Auwera Ilse; Merajver Sofia D; Van Marck Eric A; van Dam Peter; Vermeulen Peter B; Dirix Luc Y; van Golen Kenneth L
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Breast cancer research and treatment 2006;95(3):219-28.
-
2006: Zhang Lizhi; Chenwei Li; Mahmood Redah; van Golen Kenneth; Greenson Joel; Li Gangyong; D'Silva Nisha J; Li Xiangquan; Burant Charles F; Logsdon Craig D; Simeone Diane M
Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer.
Cancer research 2006;66(2):898-906.
-
2005: Zhang Xihong; Lin Min; van Golen Kenneth L; Yoshioka Kiyoko; Itoh Kazuyuki; Yee Douglas
Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration.
Breast cancer research and treatment 2005;93(2):159-68.
-
2005: Kleer Celina G; Griffith Kent A; Sabel Michael S; Gallagher Gary; van Golen Kenneth L; Wu Zhi-Fen; Merajver Sofia D
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
Breast cancer research and treatment 2005;93(2):101-10.
-
2005: Arumugam Thiruvengadam; Simeone Diane M; Van Golen Kenneth; Logsdon Craig D
S100P promotes pancreatic cancer growth, survival, and invasion.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5356-64.
-
2005: Radunsky Galina S; van Golen Kenneth L
The current understanding of the molecular determinants of inflammatory breast cancer metastasis.
Clinical & experimental metastasis 2005;22(8):615-20.
-
2005: Lin Min; DiVito Melinda M; Merajver Sofia D; Boyanapalli Madanamohan; van Golen Kenneth L
Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1.
Molecular cancer 2005;4(1):21.
-
2004: Meyer Amy; van Golen Cynthia M; Kim Bhumsoo; van Golen Kenneth L; Feldman Eva L
Integrin expression regulates neuroblastoma attachment and migration.
Neoplasia (New York, N.Y.) 2004;6(4):332-42.
-
2004: Lin Min; van Golen Kenneth L
Rho-regulatory proteins in breast cancer cell motility and invasion.
Breast cancer research and treatment 2004;84(1):49-60.
-
2003: van Golen Kenneth L
Inflammatory breast cancer: relationship between growth factor signaling and motility in aggressive cancers.
Breast cancer research : BCR 2003;5(3):174-9.
-
2002: Pan Quintin; Kleer Celina G; van Golen Kenneth L; Irani Jennifer; Bottema Kristen M; Bias Carlos; De Carvalho Magda; Mesri Enrique A; Robins Diane M; Dick Robert D; Brewer George J; Merajver Sofia D
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
Cancer research 2002;62(17):4854-9.
-
2002: van Golen Kenneth L; Bao LiWei; Brewer George J; Pienta Kenneth J; Kamradt Jeffrey M; Livant Donna L; Merajver Sofia D
Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.
Neoplasia (New York, N.Y.) 2002;4(5):373-9.
-
2002: Kleer Celina G; Tseng Michael D; Gutsch David E; Rochford Rosemary A; Wu Zhifen; Joynt Lynn K; Helvie Mark A; Chang Tammy; Van Golen Kenneth L; Merajver Sofia D
Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(7):759-64.
-
2002: Noujaim Daniel; van Golen Cynthia M; van Golen Kenneth L; Grauman Alyssa; Feldman Eva L
N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells.
Oncogene 2002;21(29):4549-57.
-
2002: van Golen Kenneth L; Bao LiWei; DiVito Melinda M; Wu ZhiFen; Prendergast George C; Merajver Sofia D
Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.
Molecular cancer therapeutics 2002;1(8):575-83.
-
2002: Kleer Celina G; Zhang Yanhong; Pan Quintin; van Golen Kenneth L; Wu Zhi-Fen; Livant D; Merajver Sofia D
WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.
Oncogene 2002;21(20):3172-80.
-
2002: Khan Mohamed K; Miller Meredith W; Taylor Jeremy; Gill Navkiranjit K; Dick Robert D; Van Golen Kenneth; Brewer George J; Merajver Sofia D
Radiotherapy and antiangiogenic TM in lung cancer.
Neoplasia (New York, N.Y.) 2002;4(2):164-70.
-
2002: Kleer Celina G; van Golen Kenneth L; Zhang Yanhong; Wu Zhi-Fen; Rubin Mark A; Merajver Sofia D
Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.
The American journal of pathology 2002;160(2):579-84.
-
2002: van Golen Kenneth L; Bao Li Wei; Pan Quintin; Miller Fred R; Wu Zhi Fen; Merajver Sofia D
Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.
Clinical & experimental metastasis 2002;19(4):301-11.
-
2001: Kleer C G; van Golen K L; Braun T; Merajver S D
Persistent E-cadherin expression in inflammatory breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(5):458-64.
-
2000: van Golen K L; Wu Z F; Qiao X T; Bao L W; Merajver S D
RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
Cancer research 2000;60(20):5832-8.
-
2000: van Golen K L; Wu Z F; Qiao X T; Bao L; Merajver S D
RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.
Neoplasia (New York, N.Y.) 2000;2(5):418-25.
-
2000: Kleer C G; van Golen K L; Merajver S D
Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.
Breast cancer research : BCR 2000;2(6):423-9.
-
1999: van Golen K L; Davies S; Wu Z F; Wang Y; Bucana C D; Root H; Chandrasekharappa S; Strawderman M; Ethier S P; Merajver S D
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2511-9.
-
1999: van Golen K; Milliron K; Davies S; Merajver S D
BRCA-associated cancer risk: molecular biology and clinical practice.
The Journal of laboratory and clinical medicine 1999;134(1):11-8.
-
1998: Owen-Schaub L B; van Golen K L; Hill L L; Price J E
Fas and Fas ligand interactions suppress melanoma lung metastasis.
The Journal of experimental medicine 1998;188(9):1717-23.
-
1997: Brader K R; Wolf J K; Hung M C; Yu D; Crispens M A; van Golen K L; Price J E
Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):2017-24.
-
1996: van Golen K L; Risin S; Staroselsky A; Berger D; Tainsky M A; Pathak S; Price J E
Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.
Clinical & experimental metastasis 1996;14(2):95-106.
Sign-in to see more
